> The problem isn't monopolized pharmaceuticals True. The problem is IP law. > nor is it too much regulation, it's too little IP law is a form of regulation

> The problem isn't monopolized pharmaceuticals True. The problem is IP law. > nor is it too much regulation, it's too little IP law is a form of regulation > Other countries simply accept that there is a monopoly There wouldn't be, if not for IP law > that therefore the prices will be sky high, if they allow the companies to just set the prices to whatever they want They can only set the prices so high because they have a government-enforced monopoly on those products due to IP law The US needs to focus on further opening markets. Make the markets more easily accessible to competition. That means reducing the regulatory restrictions to something reasonable and, like you suggest, opening all markets for competition from everywhere. I would love to be able to just buy catastrophic healthcare insurance for unforeseen or accidental injuries or illnesses, and just paying for healthcare checkups out-of-pocket. But is that option open to me? Not really. I'm open to considering the idea of implementing a nationwide single payer system but I'd prefer it to be handled on a per-state basis first to test how it would work, and what kinds of unforeseen consequences it would have.